Drug firm Ranbaxy Laboratories reported a consolidated net loss of Rs 580.14 crore for the second quarter ended June 30, 2012. The company had posted a net profit of Rs 245.53 crore during the same period of previous year, Ranbaxy Laboratories said in a filing to the BSE. [caption id=attachment_412356 align=alignleft width=380